0000000000719020

AUTHOR

W. Scheurlen

showing 1 related works from this author

Preradiation chemotherapy of children and young adults with malignant brain tumors: Results of the german pilot trial HIT'88/'89

1998

Background Preradiation chemotherapy could be beneficial in malignant brain tumors, because the blood-brain tumor-barrier is disrupted after surgery, bone marrow recovery--essential for intense chemotherapy--is still intact, and CNS toxicity and ototoxicity of active drugs are lower before irradiation of a child's brain. Patients and methods A neoadjuvant phase 2 and a single arm pilot trial were initiated to investigate the efficacy and toxicity of an intense multidrug regimen before radiotherapy in 147 patients aged between 3 and 29; 9 years with medulloblastoma (94), malignant glioma (22), ependymoma (21), and stPNET (10). They were treated with one or two cycles consisting of procarbazi…

AdultMaleOncologyEpendymomamedicine.medical_specialtyAdolescentmedicine.medical_treatmentPilot ProjectsProcarbazineInternal medicineGliomaAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansChildSurvival rateMedulloblastomaChemotherapyIfosfamideDose-Response Relationship DrugBrain Neoplasmsbusiness.industrymedicine.diseaseCombined Modality TherapyNeoadjuvant TherapySurgerySurvival RateRegimenChild PreschoolPediatrics Perinatology and Child HealthFemalebusinessFollow-Up Studiesmedicine.drug
researchProduct